The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 16.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 157%. Our forward projection puts the odds of a 10% gain over the next month near 34%. Insiders have been net buyers over the past quarter.
Burning Rock Biotech Ltd ADR BNR
Outside both standardsAn entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States.
read at $9.97
Burning Rock Biotech Ltd ADR holds its Markup at $9.97.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 2 days |
| Price | $9.97 |
| Valuation | N/A trailing · -17.19 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 1.33 |
The business, in plain words · what the numbers mean
| Forward P/E | -17.2x |
| Revenue growth | -18.9% revenue is shrinking |
| Profit margin | -11.5% currently unprofitable |
| Return on equity | -10.9% not currently earning a positive return on equity |
| Debt to equity | 0.10 minimal debt — a conservative balance sheet |
| Current ratio | 3.05 comfortably covers its short-term bills |
| Beta | 1.33 moves a little more than the market |
| Market cap | $105M |
| Employees | 667 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in BNR's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading oversold. Over the past year the shares are up 157%. Our forward projection puts the odds of a 10% gain over the next month near 34%.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Han Yusheng | Dir | Purchase | 731,410 | $4 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $16.21 | -48.6% | · | $515 | -48.6% |
| 2 months | $15.85 | -47.4% | · | $526 | -47.4% |
| 3 months | $22.85 | -63.5% | · | $365 | -63.5% |
| 6 months | $17.05 | -51.1% | · | $489 | -51.1% |
| 1 year | $3.24 | +157.4% | · | $2,574 | +157.4% |
| 2 years | $7.80 | +6.9% | · | $1,069 | +6.9% |
| 3 years | $22.00 | -62.1% | · | $379 | -62.1% |
| 5 years | $296.70 | -97.2% | · | $28 | -97.2% |
Historical returns from market close data. Past performance does not guarantee future results.